SPINRAZA® (nusinersen)
Sign in
@ProfileFirstName @ProfileLastName

X

  • Edit profile
  • Privacy
  • Security
  • Logout
  • ABOUT SMA
    • Mechanism of disease
    • Natural History
  • SPINRAZA® essentials
    • Mechanism of action
    • SAFETY
    • Posology
    • Storage and handling
    • Administration
    • Technology behind SPINRAZA®
  • SPINRAZA® study programme
    • Overview
    • Infantile-onset (Type I) SMA
    • Later-onset (Type II/III) SMA
    • Pre-symptomatic SMA
    • MIXED SMA populations
    • Ongoing studies
    • Real World Evidence
  • Events & news
    • Upcoming congresses
    • Awards
    • Local News
  • SPINRAZA® patients
    • ADULTS
    • Infants & Peds
    • Patient support programme
    • Patient profiles
  • Clinical resources
    • Latest clinical data
    • SCOPE tool
    • Motor function features
    • SPINRAZA® Media Hub
    • Book a visit
    • Ukraine resources
  • Overview
  • Infantile-onset (Type I) SMA
  • Later-onset (Type II/III) SMA
  • Pre-symptomatic SMA
  • MIXED SMA populations
  • Ongoing studies
  • Real World Evidence

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. To report safety concerns, please contact your local Biogen affiliate or consult your local prescribing information.

About SMA Mechanism of disease Natural History SPINRAZA® essentials Mechanism of action Safety Posology Storage and handling Administration Technology behind SPINRAZA®
SPINRAZA® study programme
Overview Infantile-onset (Type I) SMA Later-onset (Type II/III) SMA Pre-symptomatic SMA Mixed SMA populations Ongoing studies Real World Evidence
Events & News
Upcoming congresses Awards Local news SPINRAZA® patients Adults Infants & Peds Patient support programme Patient profiles
Clinical resources
Latest clinical data SCOPE tool Motor function features SPINRAZA® MEDIA HUB Book a visit Ukraine Resources 
  • HCP Site
  • Patient Site
  • Safety Information
  • Prescribing Information
  • Prescribing Information en Español
  • HCP Site
  • Patient Site
  • Safety Information
  • Prescribing Information
  • Prescribing Information en Español
Biogen logo
Privacy Policy Terms and Conditions Cookies

©2021 Biogen. All rights reserved.

This site is intended for EU healthcare professionals only.

 

Biogen-53476. Date of preparation: April2020.

Biogen International GmbH Neuhofstrasse 30, 6340 Baar, Switzerland.